PT  - JOURNAL ARTICLE
AU  - Fejzo, Marlena
AU  - Wang, Xinran
AU  - Zöllner, Julia
AU  - Pujol-Gualdo, Natàlia
AU  - Laisk, Triin
AU - Estonian Biobank Research Team
AU  - Finer, Sarah
AU  - van Heel, David A.
AU - Genes & Health Research Team
AU  - Brumpton, Ben
AU  - Bhatta, Laxmi
AU  - Hveem, Kristian
AU  - Jasper, Elizabeth A.
AU  - Velez Edwards, Digna R.
AU  - Hellwege, Jacklyn N.
AU  - Edwards, Todd
AU  - Jarvik, Gail P.
AU  - Luo, Yuan
AU  - Khan, Atlas
AU  - MacGibbon, Kimber
AU  - Gao, Yuan
AU  - Ge, Gaoxiang
AU  - Averbukh, Inna
AU  - Soon, Erin
AU  - Angelo, Michael
AU  - Magnus, Per
AU  - Johansson, Stefan
AU  - Njølstad, Pål R.
AU  - Vaudel, Marc
AU  - Shu, Chang
AU  - Mancuso, Nicholas
TI  - Multi-ancestry GWAS of severe pregnancy nausea and vomiting identifies risk loci associated with appetite, insulin signaling, and brain plasticity
AID  - 10.1101/2024.11.19.24317559
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.11.19.24317559
4099  - http://medrxiv.org/content/early/2024/11/20/2024.11.19.24317559.short
4100  - http://medrxiv.org/content/early/2024/11/20/2024.11.19.24317559.full
AB  - While most pregnancies are affected by nausea and vomiting, hyperemesis gravidarum (HG) is at the severe end of the clinical spectrum and is associated with dehydration, undernutrition, and adverse maternal, fetal, and child outcomes. Herein we performed a multi-ancestry genome-wide association study (GWAS) of severe nausea and vomiting of pregnancy of 10,974 cases and 461,461 controls across European, Asian, African, and Latino ancestries. We identified ten significantly associated loci, of which six were novel (SLITRK1, SYN3, IGSF11, FSHB, TCF7L2, and CDH9), and confirmed previous genome-wide significant associations with risk genes GDF15, IGFBP7, PGR, and GFRAL. In a spatiotemporal analysis of placental development, GDF15 and TCF7L2 were expressed primarily in extra villous trophoblast, and using a weighted linear model of maternal, paternal, and fetal effects, we confirmed opposing effects for GDF15 between maternal and fetal genotype. Conversely, IGFBP7 and PGR were primarily expressed in developing maternal spiral arteries during placentation, with effects limited to the maternal genome. Risk loci were found to be under significant evolutionary selection, with the strongest effects on nausea and vomiting mid-pregnancy. Selected loci were associated with abnormal pregnancy weight gain, pregnancy duration, birth weight, head circumference, and pre-eclampsia. Potential roles for candidate genes in appetite, insulin signaling, and brain plasticity provide new pathways to explore etiological mechanisms and novel therapeutic avenues.Competing Interest StatementFejzo has competing interests: Hyperemesis Education and Research (HER) Foundation (voluntary, unpaid Board member and Research Director) Harmonia Healthcare (CSO, stock, paid consultant) NGM Biosciences (stock, paid consultant) Foundation for Women's Health (Board member, voluntary, unpaid) Funding StatementFunding N.P.G. was supported by MATER Marie Sklodowska Curie which received funding from the European Union Horizon 2020 research and innovation program under grant agreement No. 813707. M.A. supported by 5U54CA20997105, 5DP5OD01982205, 1R01CA24063801A1, 5R01AG06827902, 5UH3CA24663303, 5R01CA22952904, 1U24CA22430901, 5R01AG05791504 and 5R01AG05628705 from the NIH, W81XWH2110143 from the DOD, and other funding from the Bill and Malinda Gates Foundation, the Cancer Research Institute, the Parker Center for Cancer Immunotherapy, and the Breast Cancer Research Foundation. I.A. is an awardee of the Weizmann Institute of Science Israel National Postdoctoral Award Program for Advancing Women in Science. E.S. is supported by National Science Scholarship, Agency for Science, Technology, and Research (A*STAR), Singapore. YG and GG supported by Shanghai Municipal Science and Technology Major Project. Genes & Health is/has recently been core-funded by Wellcome (WT102627, WT210561), the Medical Research Council (UK) (M009017, MR/X009777/1, MR/X009920/1), Higher Education Funding Council for England Catalyst, Barts Charity (845/1796), Health Data Research UK (for London substantive site), and research delivery support from the NHS National Institute for Health Research Clinical Research Network (North Thames). Genes & Health is/has recently been funded by Alnylam Pharmaceuticals, Genomics PLC; and a Life Sciences Industry Consortium of Astra Zeneca PLC, Bristol-Myers Squibb Company, GlaxoSmithKline Research and Development Limited, Maze Therapeutics Inc, Merck Sharp & Dohme LLC, Novo Nordisk A/S, Pfizer Inc, Takeda Development Centre Americas Inc. Dr. Elizabeth A. Jasper was supported by the NIH Building Interdisciplinary Research Career's in Women's Health career development program (K12AR084232 PIs: A.S. Major, and D.R. Velez Edwards). B.M.B., L.B. and K.H. work in a research unit funded by the Liaison Committee for education, research and innovation in Central Norway and the Joint Research Committee between St. Olavs Hospital and the Faculty of Medicine and Health Sciences, NTNU. N.M. was supported in part by NIH under awards R01HG012133, R01CA258808, R01GM140287, and U54HG013243. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was obtained for this study from the review board of the University of Southern California.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes